Comments on: Riliprubart by Sanofi for Polyradiculoneuropathy: Likelihood of Approval /data-insights/riliprubart-sanofi-polyradiculoneuropathy-likelihood-of-approval/ The leading site for news and procurement in the pharmaceutical industry Wed, 24 Jan 2024 19:29:11 +0000 hourly 1 https://wordpress.org/?v=6.7.2